Triazolam
Back to searchMolecule Structure
Scientific Name
Triazolam
Description of the Drug
Triazolam is a benzodiazepine used for short term treatment of insomnia.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB00897
http://www.drugbank.ca/drugs/DB00897
Brand Name(s)
Halcion, Kention, Triazolam
Company Owner(s)
Watson Laboratories Inc, Novast Laboratories Ltd, Mylan Pharmaceuticals Inc, Hikma Pharmaceuticals Usa Inc, Pfizer Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| Atlas | triazolam | |
| SureChEMBL | SCHEMBL29228 | |
| PharmGKB | PA451753 | |
| Human Metabolome Database | HMDB0015034 | |
| DrugBank | DB00897 | |
| PubChem: Thomson Pharma | 14875826 | |
| PubChem | 5556 | |
| Nikkaji | J9.291F | |
| BindingDB | 50001765 | |
| EPA CompTox Dashboard | DTXSID6046763 | |
| DrugCentral | 2729 | |
| Guide to Pharmacology | 7313 | |
| rxnorm | TRIAZOLAM | HALCION |
| PubChem: Drugs of the Future | 12013397 | |
| ChEBI | 9674 | |
| ZINC | ZINC000000002212 |
